⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 20, 2015Science Translational MedicineOpen Access

Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Marrow-infiltrating lymphocytes (MILs) may be used as adoptive cell therapy for multiple myeloma.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Noonan et al. (2015) studied this question.

synapsesocial.com/papers/6a0890f41e8b9db648de17a0 https://doi.org/10.1126/scitranslmed.aaa7014

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphomaPrognostic Study · 2001 · 269 citations
2Central memory self/tumor-reactive CD8 <sup>+</sup> T cells confer superior antitumor immunity compared with effector memory T cellsIn Vitro Study · 2005 · 992 citations
3Lenalidomide-Induced Immunomodulation in Multiple Myeloma: Impact on Vaccines and Antitumor ResponsesCohort Study · 2012 · 123 citations
4T cell homeostatic proliferation elicits effective antitumor autoimmunityOriginal Research · 2002 · 309 citations
5Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primatesOriginal Research · 2008 · 843 citations